Biodexa Pharmaceuticals Plc (BDRX)
1.245
-0.08
(-5.68%)
USD |
NASDAQ |
May 02, 16:00
1.24
0.00 (0.00%)
After-Hours: 20:00
Biodexa Pharmaceuticals 1 Year Total Returns (Daily): -92.30% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -92.30% |
May 01, 2024 | -92.49% |
April 30, 2024 | -91.66% |
April 29, 2024 | -92.76% |
April 26, 2024 | -93.75% |
April 25, 2024 | -96.23% |
April 24, 2024 | -96.46% |
April 23, 2024 | -96.32% |
April 22, 2024 | -96.52% |
April 19, 2024 | -96.68% |
April 18, 2024 | -96.38% |
April 17, 2024 | -96.08% |
April 16, 2024 | -95.66% |
April 15, 2024 | -95.85% |
April 12, 2024 | -95.48% |
April 11, 2024 | -95.69% |
April 10, 2024 | -95.37% |
April 09, 2024 | -95.69% |
April 08, 2024 | -95.51% |
April 05, 2024 | -95.82% |
April 04, 2024 | -94.78% |
April 03, 2024 | -95.42% |
April 02, 2024 | -95.64% |
April 01, 2024 | -95.32% |
March 28, 2024 | -95.92% |
Date | Value |
---|---|
March 27, 2024 | -97.72% |
March 26, 2024 | -99.12% |
March 25, 2024 | -98.93% |
March 22, 2024 | -99.06% |
March 21, 2024 | -99.08% |
March 20, 2024 | -99.01% |
March 19, 2024 | -99.10% |
March 18, 2024 | -99.01% |
March 15, 2024 | -98.96% |
March 14, 2024 | -98.99% |
March 13, 2024 | -98.94% |
March 12, 2024 | -98.98% |
March 11, 2024 | -98.95% |
March 08, 2024 | -99.01% |
March 07, 2024 | -99.17% |
March 06, 2024 | -99.22% |
March 05, 2024 | -99.20% |
March 04, 2024 | -99.19% |
March 01, 2024 | -99.24% |
February 29, 2024 | -99.24% |
February 28, 2024 | -99.21% |
February 27, 2024 | -99.15% |
February 26, 2024 | -99.20% |
February 23, 2024 | -99.15% |
February 22, 2024 | -99.10% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.65%
Minimum
Jul 07 2023
111.2%
Maximum
Jun 18 2021
-63.28%
Average
-75.21%
Median
Jul 29 2020
1 Year Total Returns (Daily) Benchmarks
Adaptimmune Therapeutics PLC | -13.14% |
NuCana PLC | -79.67% |
Autolus Therapeutics PLC | 109.7% |
Mereo BioPharma Group PLC | 159.2% |
Bicycle Therapeutics PLC | 20.50% |